The Advisory Board Company (NASDAQ:ABCO) – Stock analysts at KeyCorp reduced their Q4 2016 earnings estimates for The Advisory Board Company in a research note issued on Tuesday. KeyCorp analyst D. Hooker now forecasts that the brokerage will earn $0.42 per share for the quarter, down from their previous estimate of $0.47. KeyCorp also issued estimates for The Advisory Board Company’s Q1 2017 earnings at $0.34 EPS, Q3 2017 earnings at $0.36 EPS and Q4 2017 earnings at $0.44 EPS.

ABCO has been the topic of a number of other research reports. Zacks Investment Research downgraded The Advisory Board Company from a “hold” rating to a “sell” rating in a research report on Tuesday, January 3rd. Credit Suisse Group reiterated a “buy” rating and set a $50.00 price target on shares of The Advisory Board Company in a research report on Friday, September 16th. Barclays PLC increased their price target on The Advisory Board Company from $44.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, September 30th. Stifel Nicolaus reduced their target price on The Advisory Board Company from $45.00 to $43.00 and set a “hold” rating for the company in a report on Wednesday, November 2nd. Finally, Cantor Fitzgerald reissued a “neutral” rating on shares of The Advisory Board Company in a report on Thursday, November 3rd. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $42.56.

COPYRIGHT VIOLATION WARNING: This article was posted by Daily Political and is the propert of of Daily Political. If you are accessing this article on another site, it was illegally copied and republished in violation of US and international trademark and copyright law. The original version of this article can be accessed at http://www.dailypolitical.com/2017/01/13/keycorp-brokers-cut-earnings-estimates-for-the-advisory-board-company-abco.html.

The Advisory Board Company (NASDAQ:ABCO) traded down 0.12% during trading on Friday, reaching $41.95. The company had a trading volume of 535,057 shares. The Advisory Board Company has a 52 week low of $18.87 and a 52 week high of $48.86. The company’s 50-day moving average is $33.88 and its 200 day moving average is $38.68. The firm’s market capitalization is $1.68 billion.

The Advisory Board Company (NASDAQ:ABCO) last announced its earnings results on Tuesday, November 1st. The company reported $0.28 EPS for the quarter, missing the Zacks’ consensus estimate of $0.40 by $0.12. The company earned $200.50 million during the quarter, compared to analysts’ expectations of $203.35 million. The Advisory Board Company had a positive return on equity of 11.28% and a negative net margin of 5.77%. The Advisory Board Company’s revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.33 EPS.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ABCO. Quantbot Technologies LP purchased a new position in The Advisory Board Company during the third quarter valued at approximately $110,000. BlackRock Inc. raised its position in The Advisory Board Company by 16.2% in the second quarter. BlackRock Inc. now owns 3,263 shares of the company’s stock valued at $116,000 after buying an additional 455 shares in the last quarter. BlackRock Japan Co. Ltd raised its position in The Advisory Board Company by 102.7% in the third quarter. BlackRock Japan Co. Ltd now owns 2,820 shares of the company’s stock valued at $126,000 after buying an additional 1,429 shares in the last quarter. BNP Paribas Arbitrage SA raised its position in The Advisory Board Company by 111.7% in the third quarter. BNP Paribas Arbitrage SA now owns 3,428 shares of the company’s stock valued at $153,000 after buying an additional 1,809 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in The Advisory Board Company during the third quarter valued at approximately $182,000.

COPYRIGHT VIOLATION WARNING: This article was posted by Daily Political and is the propert of of Daily Political. If you are accessing this article on another site, it was illegally copied and republished in violation of US and international trademark and copyright law. The original version of this article can be accessed at http://www.dailypolitical.com/2017/01/13/keycorp-brokers-cut-earnings-estimates-for-the-advisory-board-company-abco.html.

In other news, CEO Robert W. Musslewhite sold 5,500 shares of the firm’s stock in a transaction on Monday, December 12th. The stock was sold at an average price of $33.87, for a total transaction of $186,285.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Michael T. Kirshbaum sold 2,400 shares of the firm’s stock in a transaction on Thursday, October 20th. The stock was sold at an average price of $42.80, for a total value of $102,720.00. Following the transaction, the chief financial officer now owns 45,503 shares of the company’s stock, valued at $1,947,528.40. The disclosure for this sale can be found here. 2.90% of the stock is owned by corporate insiders.

About The Advisory Board Company

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

5 Day Chart for NASDAQ:ABCO

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.